Status:
COMPLETED
The Impact of Oral Cryotherapy and Chewing Gum Interventions
Lead Sponsor:
Hacettepe University
Conditions:
Breast Cancer
Nausea and Vomiting
Eligibility:
FEMALE
18-65 years
Phase:
NA
Brief Summary
Chemotherapy-induced nausea and vomiting (CINV) and taste alterations continue to be among the most common and most severe side effects that women receiving adjuvant chemotherapy for breast cancer suf...
Detailed Description
Chemotherapy-induced nausea and vomiting (CINV) remains one of the most distressing and prevalent side effects of cancer treatment, affecting a substantial proportion of patients undergoing chemothera...
Eligibility Criteria
Inclusion
- Women aged between 18 and 65 years,
- Scheduled to receive adjuvant chemotherapy for the first time,
- Receiving the AC protocol as their chemotherapy regimen,
- Receiving chemotherapy doses classified as moderately emetogenic (according to the International Society of Supportive Care in Cancer Guidelines),
- Not having received radiotherapy prior to adjuvant chemotherapy,
- Without chronic diseases (coronary artery disease, chronic kidney disease, or diabetes mellitus),
- Not having used any non-pharmacological method for nausea and vomiting,
- Diagnosed with breast cancer for the first time,
- Without metastasis,
- Without thrombocytopenia,
- At an early stage,
- Aware of their diagnosis,
- Open to communication and cooperation,
- Literate,
- Not receiving psychiatric and/or depression treatment,
- Not in the terminal stage,
- Willing and volunteering to participate in the study.
Exclusion
- Illiterate,
- Over 65 years of age,
- Using anxiolytic or antidepressant medications,
- Having chronic diseases (gastrointestinal obstruction/disease, hepatitis, coronary artery disease, chronic kidney disease, or diabetes mellitus),
- Having metastasis,
- Having received radiotherapy prior to adjuvant chemotherapy,
- Not willing to participate in the study.
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT07145320
Start Date
June 1 2021
End Date
May 1 2022
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hacettepe University
Ankara, Adnan Saygun, Turkey (Türkiye), 06100